Butyrolactone V
Butyrolactone V is a butanolide compound. Butyrolactone V shows antiplasmodial activity against Plasmodium falciparum K1 with an IC50 of 7.9 µg/ml[1].
Product Specifications
CAS Number
[1151509-01-1]
UNSPSC
12352005
Target
Parasite
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/butyrolactone-v.html
Solubility
10 mM in DMSO
Smiles
O=C([C@](C(C1=CC=C(O)C=C1)=C2O)(CC3=CC=C4C(C[C@H](O)C(C)(C)O4)=C3)OC2=O)OC
Molecular Formula
C24H24O8
Molecular Weight
440.44
References & Citations
[1]Haritakun R, et al. Butyrolactones from the fungus Aspergillus terreus BCC 4651. Chem Pharm Bull (Tokyo) . 2010;58 (11) :1545-1548.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
Plasmodium
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1400902-01 0.02 mg (E-Coli)
Recombinant Bordetella pertussis Lipoprotein-releasing system ATP-binding protein LolD (lolD)
Ask
View Details MBS1400902-02 0.1 mg (E-Coli)
Recombinant Bordetella pertussis Lipoprotein-releasing system ATP-binding protein LolD (lolD)
Ask
View Details 
MBS1400902-03 0.02 mg (Yeast)
Recombinant Bordetella pertussis Lipoprotein-releasing system ATP-binding protein LolD (lolD)
Ask
View Details MBS1400902-04 0.1 mg (Yeast)
Recombinant Bordetella pertussis Lipoprotein-releasing system ATP-binding protein LolD (lolD)
Ask
View Details MBS1400902-05 0.02 mg (Baculovirus)
Recombinant Bordetella pertussis Lipoprotein-releasing system ATP-binding protein LolD (lolD)
Ask
View Details